Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Journal of the American College of Cardiology|December 6, 2023
Research Priorities in Critical Care Cardiology: JACC Expert PanelP Elliott Miller, Kurt Huber, Erin A Bohula, et al.
European Heart Journal|October 25, 2007
The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-upMartin Busk, Michael Maeng, Klaus Rasmussen, et al.
European Journal of Clinical Investigation|March 19, 2019
Predicting stroke in patients without atrial fibrillationKamilla Steensig, Kevin K W Olesen, Troels Thim, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 19, 2020
Platelet aggregation and response to aspirin therapy in cardiac allograft vasculopathyKamilla P Bjerre, Tor S Clemmensen, Katrine Berg, et al.
Thrombosis and Haemostasis|November 13, 2018
Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart RegistryKamilla Steensig, Kevin K W Olesen, Troels Thim, et al.
Cardiology|November 14, 2008
Clinical reinfarction according to infarct location and reperfusion modality in patients with ST elevation myocardial infarction. A DANAMI-2 long-term follow-up substudyMartin Busk, Steen D Kristensen, Klaus Rasmussen, et al.
European Heart Journal|September 11, 2019
16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarctionPernille G Thrane, Steen D Kristensen, Kevin K W Olesen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 10, 2013
Feasibility and early safety of hybrid coronary revascularisation combining off-pump coronary surgery through J-hemisternotomy with percutaneous coronary interventionIvy S Modrau, Per H Nielsen, Hans E Bøtker, et al.
American Heart Journal|May 29, 2018
Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) X trialLars Jakobsen, Evald H Christiansen, Michael Maeng, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 29, 2017
Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stentsLars Jakobsen, Evald Høj Christiansen, Michael Maeng, et al.
Pageof 9